This session will provide a valuable introduction to contemporary healthcare economics and an understanding of its role. The pressure upon drug and device developers to provide more cost-effective therapies is significant and continually increasing. When conducting a clinical trial, the collection of important economic data in conjunction with medical and clinical outcomes is becoming more common. An understanding of the routine conduct of economic evaluations alongside the traditional analyses of safety and efficacy is important for all clinical research professionals. Speakers will review various pharmacoeconomic research designs (cost-minimization analysis, cost-effectiveness analysis, cost-utility analysis, and cost-benefit analysis) using case studies, and explain the concept of quality-adjusted life years which has evolved into one of the leading outcomes in pharmacoeconomic evaluations.
Contact Hours/CEUs: 1.0